Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
Seeking an experienced fill/finish partner with available capacity today? You have come to the right place.
Are you an innovative company seeking a reliable CDMO partner to help move your drug substance program to its next phase of success? Look no further.
Event Overview: The Life Sciences industry relies on vast amounts of data to rapidly evaluate their novel therapies confidently at a global scale. To...
The Cytiva SA25 Aseptic Filling Workcell is a standardized system designed with flexibility built in. As an industry partner and collaborator,...
Download this on demand presentation detailing our drug substance manufacturing and drug product fill/finish capabilities. Simplify your GENE to IND...
The need for advanced technology platforms that offer a clear, end-to-end path to commercial manufacturing is driving biotech companies to outsource...
RESILIENCE